Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
| Image |  |
|---|---|
| Description | scientific article published on 20 July 2020 |
| Author/s |
author: Markus Munder Steffen Luntz Martin Goerner Mathias Hänel German-speaking Myeloma Multicenter Group (GMMG) Sandra Sauer Marc S Raab Stephan Fuhrmann Hartmut Goldschmidt Dirk Hose Katja Weisel Anja Seckinger Hans-Walter Lindemann Elias Karl Mai Hans Salwender Jan Dürig Ahmet Elmaağaçlı Maximilian Merz Axel Benner Uta Bertsch Peter Brossart Christof Scheid |
| Publication date | July 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |